Healthtech Startups
16,920 companies tagged Healthtech, with their investors and founders.
Ethyreal Bio is a biopharmaceutical company developing medicines for people with Thyroid Eye Disease and Graves' Disease. It focuses on antibody and other therapeutic programs in the endocrine/immunology space.
2 investors
EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions. The company positions itself as a provider of comprehensive, research-driven solutions to CGT challenges.
2 investors
Everi builds software for orthotics and prosthetics (O&P) clinics to reduce administrative burden and documentation work, allowing clinicians to focus more on patient care. The platform was designed in collaboration with clinic staff to address real workflows and operational pain points.
2 investors
Everlab is a digital health platform offering personalized preventative medicine and longevity testing across Australia, combining bloodwork diagnostics, genetic testing, and specialist access with an app-based care coordination system guided by longevity-trained doctors.
2 investors
Every Mother provides evidence-based exercise programs focused on core and pelvic floor health for women across different life stages. The company delivers personalized, digital exercise solutions for health conditions like diastasis recti, urinary incontinence, and back pain.
2 investors
FitnessSyncer is a health and fitness data aggregation platform that unifies data from multiple apps, trackers, and devices in a single dashboard. It provides analysis, visualization, and synchronization tools for users to track and share their fitness and health metrics across various services.
2 investors
Evidently builds AI-assisted tools that help clinicians access and work with patient data more efficiently, including chart summarization, note drafting, and denial appeal management for U.S. healthcare organizations.
2 investors
Evidium provides predictive analytics and clinical progression modeling for self-insured health plans and employers, forecasting disease evolution and high-cost claim exposure to improve stop-loss underwriting and financial planning. The platform serves plan sponsors, health plans, and other stakeholders in the self-insured benefits ecosystem by converting medical knowledge into actionable insights for managing health plan risk.
2 investors
Evity builds a platform that translates longevity and healthspan research into clinical tools and patient-accessible information. The company serves clinicians and patients seeking evidence-based prevention informed by advances in medical science.
2 investors
Publicly traded Arlington, Virginia healthcare company delivering clinical and financial results for value-based care providers.
2 investors
Evolve Biosystems develops probiotic strains of B. infantis, including EVC001 and a next-generation drug strain INF108, aimed at supporting the infant gut microbiome and preventing necrotizing enterocolitis (NEC) in premature infants. The company works at the intersection of breast milk research and infant health in the biotech and digital/medical therapeutics space.
2 investors
Evozyne designs and builds engineered protein therapeutics using an AI-native platform, focusing on treatments for immune-mediated diseases. The company develops novel biologics and a pipeline of engineered proteins aimed at clinical use.
2 investors
Evry provides members with access to a team of nurses, nutritionists, and doctors who coordinate personalized care plans and help members navigate health services. The service bundles wellness programs, reward incentives, and care coordination for individual health plan members.
2 investors
ExaCare builds AI-powered software to coordinate operations and information across post-acute care settings, including skilled nursing, home health, and transitions between hospitals. It serves post-acute care teams and operators in the healthcare industry.
2 investors
Exact Sciences develops molecular diagnostic tests for cancer screening and detection, including multitarget stool DNA testing for colorectal cancer and multigene assays for breast cancer recurrence. The company serves patients and healthcare providers in the cancer diagnostics field.
2 investors
Exero Medical develops the xBar system, which uses electrode sensors embedded in a standard surgical drain to non-invasively monitor post-operative tissue healing and detect anastomotic leaks after gastrointestinal surgery. The system provides healthcare providers with post-operative data to enable earlier detection of complications; it is currently limited to investigational use in the US.
2 investors
Eximis Surgical develops a minimally invasive specimen removal device for use in abdominal surgery, enabling surgeons to remove surgical specimens through small incisions rather than requiring larger incisions at the end of procedures. The device targets patients undergoing minimally invasive surgical procedures to reduce postoperative pain and recovery time.
2 investors
Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors. It develops cell therapies aimed at cancer treatment by mining the TCR sequence space to identify safe, non-cross-reactive receptors against shared tumor targets.
2 investors
2 investors
Eyas Medical Imaging develops MRI technology designed specifically for imaging babies and infants. The company serves healthcare professionals and hospitals seeking precision imaging solutions for neonatal and pediatric patients.
2 investors
EyeYon Medical develops medical devices for corneal diseases, including EndoArt®, a synthetic implant for chronic corneal edema, and HyperCL™, a therapeutic contact lens for enhancing drug absorption in corneal conditions. The company serves ophthalmologists and patients requiring alternatives to traditional corneal transplantation.
2 investors
EyeControl builds a communication and engagement platform for critical care, helping hospitals support patient recovery and connection between patients, families, and medical teams, with capabilities extending to home care. It originated as an eye-based communication tool for patients unable to speak, such as those with ALS and other neurological conditions.
2 investors
Eyemart Express operates a network of local optometry and eyewear retail stores, providing vision care and eyeglass sales to consumers in their communities. The company has been serving customers for over 34 years through a model emphasizing accessible, locally-focused customer service.
2 investors
Eyoto provides eye examination technology solutions for clinics, aiming to improve accessibility and efficiency of eye care delivery.
2 investors